In the context of AD, the activation of ADAM10 has also been shown to elevate the levels of soluble triggering receptor expressed on myeloid cells-2 (sTREM2) by influencing the extracellular domain of TREM2. This evidence concerns the gene TREM2 and Alzheimer disease.